<p>*Pre-vaccination period;</p><p>**post-vaccination period;</p>#<p>OR: odds ratio.</p><p>Distribution of serotypes belonging to PCV10 among invasive pneumococci recovered from 2007 to 2012 (the distribution of all serotypes is demonstrated on the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111129#pone.0111129.s001" target="_blank">Table S1</a>).</p
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
In September 2006, the seven-valent pneumococcal conjugate vaccine (PCV7; Prevenar) was introduced i...
<p>The serotype distribution in the two periods analyzed 1999–2000 (pre-PCV7, n = 174 isolates) and ...
<p>The relative frequency of pneumococcal serotypes isolated from nasopharyngeal swabs before and af...
<p>The study periods were subdivided into three epochs and six sub-epochs: Pre-PCV7 [Epoch 1: A (n =...
Before the introduction of the heptavalent pneumococcal conjugate vaccine (Prevnar-7), the relative ...
INTRODUCTION: Before the introduction of the heptavalent pneumococcal conjugate vaccine (Prevnar-7),...
Pneumococcal conjugate vaccines (PCVs) have substantially reduced morbidity and mor-tality of pneumo...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Background: Vaccination of infants with pneumococcal conjugate vaccines (PCV) has resulted in major ...
Serotype replacement has been reported in carriage and disease after pneumococcal conjugate vaccine ...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Serotyping data for pneumococci causing invasive and noninvasive disease in 2008-2009 and 2010-2011 ...
Serotyping data for pneumococci causing invasive and noninvasive disease in 2008–2009 and 2010–2011 ...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
In September 2006, the seven-valent pneumococcal conjugate vaccine (PCV7; Prevenar) was introduced i...
<p>The serotype distribution in the two periods analyzed 1999–2000 (pre-PCV7, n = 174 isolates) and ...
<p>The relative frequency of pneumococcal serotypes isolated from nasopharyngeal swabs before and af...
<p>The study periods were subdivided into three epochs and six sub-epochs: Pre-PCV7 [Epoch 1: A (n =...
Before the introduction of the heptavalent pneumococcal conjugate vaccine (Prevnar-7), the relative ...
INTRODUCTION: Before the introduction of the heptavalent pneumococcal conjugate vaccine (Prevnar-7),...
Pneumococcal conjugate vaccines (PCVs) have substantially reduced morbidity and mor-tality of pneumo...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Background: Vaccination of infants with pneumococcal conjugate vaccines (PCV) has resulted in major ...
Serotype replacement has been reported in carriage and disease after pneumococcal conjugate vaccine ...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Serotyping data for pneumococci causing invasive and noninvasive disease in 2008-2009 and 2010-2011 ...
Serotyping data for pneumococci causing invasive and noninvasive disease in 2008–2009 and 2010–2011 ...
Pneumococcal conjugate vaccine (PCV) introduction has reduced pneumococcal meningitis incidence. The...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
In September 2006, the seven-valent pneumococcal conjugate vaccine (PCV7; Prevenar) was introduced i...